Effect of dietary protein source on calcium phosphorus product in patients with chronic kidney disease
Giornale di Clinica Nefrologica e Dialisi · 07.05.2026 · 38 (1) · 50-58
DOI: 10.33393/gcnd.2026.3626 ↗Kurz gefasst
Fachartikel in der Zeitschrift Giornale di Clinica Nefrologica e Dialisi, online erschienen am 07.05.2026. Verfasst von Sinem Bayram und 2 weiteren Autor:innen. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Cardiovascular disease is highly prevalent in chronic kidney disease (CKD) and progresses rapidly. The calcium–phosphorus product (Ca×P) is a clinically relevant mineral metabolism parameter linked to cardiovascular risk in CKD. This study compared Ca×P and related clinical features according to predominant dietary protein source.
Methods
In this cross-sectional observational study, participants with CKD (n = 80) were classified into two groups using 3-day food records: a plant-protein group (VP; n = 40; plant protein >50% of total protein intake) and an animal-protein group (AP; n = 40; animal protein >50% of total protein intake).
Results
Anthropometric measurements did not differ between groups. Phosphate-binder use and pruritus were more frequent in the AP group. Estimated glomerular filtration rate (eGFR) was higher in the VP group, whereas serum calcium, phosphorus, potassium, and Ca×P were significantly higher in the AP group. Mean Ca×P was 47.87 ± 7.65 in the AP group and 33.75 ± 5.01 in the VP group (p = 0.001). Plant protein intake was strongly inversely correlated with serum phosphorus (r = −0.628, p = 0.014). No significant between-group differences were observed for iron, albumin, triglycerides, HDL, LDL, sodium, ferritin, C-reactive protein, or uric acid (p > 0.05).
Conclusion
Predominant plant protein intake was associated with a lower Ca×P product and more favorable phosphorus-related parameters, without higher serum potassium, and with fewer phosphate-binder prescriptions and less pruritus. Larger, well-designed randomized controlled trials—particularly in predialysis CKD—are warranted to confirm these associations and clarify causality.
Zitieren
APA
Bayram, S., Izgi, H. C., & Boyaci, I. (2026). Effect of dietary protein source on calcium phosphorus product in patients with chronic kidney disease. Giornale di Clinica Nefrologica e Dialisi, 38(1), 50-58. https://doi.org/10.33393/gcnd.2026.3626
Vancouver
Bayram S, Izgi HC, Boyaci I. Effect of dietary protein source on calcium phosphorus product in patients with chronic kidney disease. Giornale di Clinica Nefrologica e Dialisi. 2026;38(1):50-58. doi:10.33393/gcnd.2026.3626
BibTeX
@article{Bayram2026,
author = {Bayram, Sinem and Izgi, Hilal Calışkan and Boyaci, Ismihan},
title = {Effect of dietary protein source on calcium phosphorus product in patients with chronic kidney disease},
journal = {Giornale di Clinica Nefrologica e Dialisi},
year = {2026},
volume = {38},
number = {1},
pages = {50--58},
doi = {10.33393/gcnd.2026.3626}
}
EUVIMED